# ORLANCE, INC.: Enhanced Seasonal Influenza Vaccine Targeting Variable and Conserved Antigens

**Lab Budget Score:** 70/100

| Field | Value |
|---|---|
| Organization | ORLANCE, INC. |
| Location | SEATTLE, WA |
| Project | Enhanced Seasonal Influenza Vaccine Targeting Variable and Conserved Antigens |
| Project number | 4R44AI186932-02 |
| Mechanism | R44 |
| Institute | National Institute of Allergy and Infectious Diseases |
| Award | $1,000,000 |
| Awarded | 2026-08-31 |
| Project period | 2024-08-08 to 2029-08-31 |
| UEI | KH6YJYH55G53 |

## Why this score
- Award of $1M or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11532352). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.